1Tigue C C, McKoy J M, Evens A M, et al. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project[J].Bone Marrow Transplant, 2007,40(3):185-192.
2De la Rubia J, De Arfiba F, Arbona C, et al, Follow-up of healthy donors receiving granulocyte colony-stimulating factor for periph- eral blood progenitor cell mobilization and collection.Results of the Spanish Donor Registry[J]. Haematologica, 2008,93(5):735-740.
3Cesaro S, Marson P, Gazzola M V, et al. The use of cytokine-stim- ulated healthy donors in allogeneic stem cell transplantation [J]. Haematologica, 2002,87(8 Suppl):35-41.
4Repine J E, Beechler C J. Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991[J]. Am Rev Respir Dis, 1991,144(2):251-252.
5L Karlin, M Darmon, G Thie' ry,et al. Respiratory status deterio- ration during G-CSF-induced neutropenia recovery[J]. Bone Marrow Transplantation,2005, 36(3):245-250.
8Fu J F, Hsu C L, Shih L Y.MLL/AF10(OM-LZ)-immortalized cells expressed cytokines and induced host cell proliferation in a mouse bone marrow transplantation model[J].Int J Cancer,2010, (7) 126:1621-1629.
1Tigue CC, McKoy JM, Evens AM, et al. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007;40(3):185-192.
2de la Rubia J, de Arriba F, Arbona C, et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica. 2008; 93(5):735-740.
3Cesaro S, Marson P, Gazzola MV, et al. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation. Haematologica. 2002;87(8 Suppl):35-41.
4Michael A, Chitphakdithai P, Miller JP, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604-3611.
5Demuynck H, Zachée P, Verhoef GE, et al. Risks of rhG-CSF treatment in drug-induced agranulocytosis. Ann Hematol. 1995; 70(3):143-147.
6Arimura K, Inoue H, Kukita T, et al. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica. 2005;90(3):27-29.
7Deeren DH, Zachee P, Malbrain ML. Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements. Ann Hematol. 2005;84(2):89-94.
8Hasegawa Y, Ninomiya H, Kamoshita M, et al. Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma. Intern Med. 1997;36(5):360-364.
9Katoh M, Shikoshi K, Takada M, et al. Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor. Ann Hematol. 1993;67(4):201-202.
10Niitsu N, Iki S, Muroi K, et al. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96. Br J Cancer. 1997; 76(12): 1661-1666.
